Mechanistically, IL-24 enhances anti-tumor immunity by promoting the secretion of pro-inflammatory cytokines e.g., Interferon (IFN-γ), Tumor necrosis factor (TNF-α), activating immune effector cells such as CD8+ T cells and NK cells. The gene discussed is TNF; the disease is neoplasm.